WallStreetZenWallStreetZen

NASDAQ: FHTX
Foghorn Therapeutics Inc Stock Ownership - Who owns Foghorn Therapeutics?

OverviewForecastEarningsDividendOwnership

Insider buying vs selling

Have Foghorn Therapeutics Inc insiders been buying or selling?
Buy
Sell
NameRoleDateSharesPriceValue
Fanny CavalieChief StrategyBus Ops Officer2024-03-1111,000$6.56
$72.14kSell
Samuel AgrestaChief Medical Officer2023-08-16311,297$8.25
$2.57MSell
Samuel AgrestaChief Medical Officer2023-08-16311,297$3.72
$1.16MBuy

1 of 1

FHTX insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when FHTX insiders and whales buy or sell their stock.

FHTX Shareholders

What type of owners hold Foghorn Therapeutics Inc stock?
Institutional
Insider
Retail
NameHoldSharesValueType
Flagship Pioneering Inc29.78%12,674,120$66.29MInstitution
Cigall Kadoch8.51%3,624,379$18.96MInsider
Fmr LLC6.60%2,810,009$14.70MInstitution
Raymond James Associates4.86%2,068,387$10.82MInstitution
Flagship Ventures Fund V General Partner LLC4.35%1,851,801$9.68MInsider
Euclidean Capital LLC3.70%1,573,761$8.23MInstitution
Blackrock Inc3.07%1,305,868$6.83MInstitution
Dhabi Investment Authority Abu2.89%1,231,081$6.44MInsider
Vanguard Group Inc2.41%1,025,113$5.36MInstitution
Artal Group Sa1.69%720,720$3.77MInstitution

1 of 3

FHTX vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
FHTX61.54%18.77%Net SellingNet Selling
QSI36.43%63.57%Net BuyingNet Buying
CDT1.86%73.61%
ACIU29.88%0.00%
VTYX39.06%60.94%Net SellingNet Selling
View Top Biotech Stocks

Foghorn Therapeutics Stock Ownership FAQ

Who owns Foghorn Therapeutics?

Foghorn Therapeutics (NASDAQ: FHTX) is owned by 61.54% institutional shareholders, 18.77% Foghorn Therapeutics insiders, and 19.69% retail investors. Cigall Kadoch is the largest individual Foghorn Therapeutics shareholder, owning 3.62M shares representing 8.51% of the company. Cigall Kadoch's Foghorn Therapeutics shares are currently valued at $19.90M.

If you're new to stock investing, here's how to buy Foghorn Therapeutics stock.
©2024 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.